MS
NTLA icon

Monetary Solutions’s Intellia Therapeutics NTLA Stock Holding History

Monetary Solutions’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.1K Hold
65
– – ﹤0.01% 312
2026
Q1 		$833 Hold
65
– – ﹤0.01% 298
2025
Q4 		$584 Buy
+65
New +$895 ﹤0.01% 300

Other funds holding NTLA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $2.17B AUM 134.87% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return

Monetary Solutions's NTLA Position: Q2 2026 in Review

Monetary Solutions held its Intellia Therapeutics (NTLA) position steady in Q2 2026 at 65 shares worth $1.1K. The position accounts for ﹤0.01% of the portfolio, ranked #312.

Monetary Solutions first reported a position in NTLA in Q4 2025 and has held it in 3 quarters since. 215 funds tracked by Wall St. Rank hold NTLA as of Q2 2026.

  • Monetary Solutions held 65 shares of Intellia Therapeutics worth $1.1K as of Q2 2026.
  • Monetary Solutions left its Intellia Therapeutics share count unchanged in Q2 2026.
  • Intellia Therapeutics made up ﹤0.01% of Monetary Solutions's portfolio in Q2 2026, its #312 holding.
  • Monetary Solutions first reported a position in Intellia Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 215 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2026.

Based on Monetary Solutions's 13F filing for Q2 2026, filed 23 Jul 2026.